Dexcom API nod from FDA

By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data of Dexcom users. Dexcom contends that the APIs will help patients and healthcare providers as both treatment information and patient-specific CGM information will be in one place and allow for ‘in-the-moment’ diabetes management coaching and feedback. Developers can integrate CGM data with their applications, diabetes management systems or devices through the new APIs, according to the announcement. Diabetes management companies like Teladoc Health’s Livongo for Diabetes and the smartwatch maker Garmin are in the testing and development phase of syncing their products with Dexcom users’ sensor data.

To read more CLICK HERE.





Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags